HeMemics is a development and manufacturing company that is privately held. Their core competence is applying HeMeDriâ¢, the HeMemics proprietary desiccation technology platform to solve preservation, storage and shipping problems that involve dehydrating and rehydrating proteins, cells and tissues. This platform can be applied to preserving blood and blood components, a wide variety of other cells, and selected tissues with or without desiccation. HeMemics has used this platform to preserve and dehydrate/rehydrate perishable biologics (proteins, cells, tissues, etc.) and has developed processes to extend the shelf life while transporting cells for medical and non-medical applications. The company has demonstrated capabilities to deliver commercial reagents for use in blood banks, hospitals and clinics and for transporting mammalian cells at ambient temperature for use in pharmaceutical or academic research labs.
